Yurista, Salva R.
Silljé, Herman H. W.
van Goor, Harry
Hillebrands, Jan-Luuk
Heerspink, Hiddo J. L.
de Menezes Montenegro, Luiz
Oberdorf-Maass, Silke U.
de Boer, Rudolf A.
Westenbrink, B. Daan
Funding for this research was provided by:
Indonesia Endowment Fund for Education (LPDP No. 20150722083422)
Hartstichting (CVON DOSIS, grant 2014-40, CVON SHE-PREDICTS-HF, grant 2017-21, and CVON RED-CVD, grant 2017-11)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO VIDI, grant 917.13.350, NWO VENI, grant 016.176.147)
Article History
First Online: 17 March 2020
Compliance with Ethical Standards
:
: The study was approved by the University of Groningen Ethical Committee on Animal Experimentation (IvD number: 16487-02-001). The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health and in accordance with national regulations.
: SRY, HHWS, HvG, JLH, HJLH, LMM, SUO and BDW do not report conflicts of interest relative to this report. The UMCG employs Dr. De Boer who has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Roche, Trevena and ThermoFisher GmbH. Dr. de Boer received personal fees from MandalMed Inc., Novartis and Servier.